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Abstract 
Introduction: Cone Beam CT imaging is prevalent in dentistry yet much is unknown with 
regard to how radiation dose to the patient varies between different CBCT scanners and 
imaging protocols.  Scanner and protocol specific effective dose calculations will aid in 
optimizing individualized protocols for clinical applications. 
Purpose: To determine the effective dose for a range of imaging protocols using the Sirona 
GALILEOS Comfort CBCT scanner.  
Materials and Methods:  Calibrated InLight nanoDot OSL dosimeters (Landauer, 
Glenwood, Ill) were placed at 26 select sites in the head and neck of a modified, human 
tissue-equivalent RANDO phantom.
 
 Effective dose was calculated using the measured local 
absorbed doses, accounting for the fractional volume and type of tissue exposed, and 
applying the 2007 ICRP
1
 tissue weighting factors. In total, 12 different scanning protocols 
were investigated varying the field of view, mAs, contrast and resolution parameters.   
Results: The effective doses for a repeated protocol (full maxillomandibular scan, maximum 
(42) mAs, high contrast and resolution) were 140, 141 and 142 µSv. This compares to 100 
µSv for a maxillary scan and 107 µSv for a mandibular scan with identical mAs, contrast and 
resolution settings. Effective dose remained between 140-142 µSv for maxillomandibular 
scans at 42 mAs with varying contrast and resolution settings.   
Conclusions:   Changes to mAs and beam collimation have a significant influence on 
effective dose.  Effective dose varies linearly with mAs.  Collimating to obtain a narrower 
maxillary or mandibular scan decreases effective dose by approximately 28% and 23% 
respectively as compared to a full maxillomandibular scan.  Changes to contrast and 
resolution settings have little influence on effective dose. This study provides data for setting 
individualized patient exposure protocols in order to minimize patient dose from ionizing 
radiation used for diagnostic or treatment planning tasks in dentistry 
Keywords:  dosimetry, radiation dosage, effective dose, cone beam computed tomography, 
CBCT 
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INTRODUCTION 
Dental radiography provides essential information in diagnosis and subsequent treatment 
planning.  While two-dimensional analog techniques continue to be employed in routine dental 
practice, digital and three-dimensional modalities are becoming increasingly common.   Digital 
radiography offers improved compatibility with practice management and imaging software, 
reduces storage needs, eliminates chemical, Silver and lead foil waste, facilitates transfer of 
images between practitioners and may offer reduced radiation exposure.
2
  Three-dimensional 
imaging techniques provide a means for interpreting the spatial relationship of structures 
otherwise superimposed on standard two-dimensional images.  This has important implications 
in dental implantology and other surgical procedures where detailed assessment of structures 
adjacent to the surgical site is essential.   In clinical situations where several two-dimensional 
images are indicated, three-dimensional techniques offer an efficient method of reconstructing 
the same group of images while limiting image acquisition to a single exposure. 
3
 
While three-dimensional images may offer abundant clinical information, it is not sufficient to 
prescribe them on the basis of convenience.  Of equal importance in determining which image to 
prescribe is the associated radiation exposure incurred by the patient.  Haphazard selection of 
images that exceed the region of interest and quality required for diagnosis exposes the patient to 
undue risk from ionizing radiation.  For this reason, guidelines suggest that radiation exposure be 
limited to as low as reasonably achievable, with the benefits from the diagnostic information 
obtained exceeding the risks incurred by exposure. 
4-6
  
The question of which radiograph to prescribe for a given patient and clinical scenario becomes a 
complex one requiring an in depth knowledge of the parameters set at image acquisition and 
their respective effects on both diagnostic image quality and patient exposure.  Obtaining an 
image with maximum field and resolution may provide the most complete set of imaging data for 
the patient but at the expense of increased radiation dose.  Determination of the appropriate 
scanning protocol must be considered in the context of the patient history, clinical findings, 
previous imaging results, differential diagnosis and treatment plan.  The scanning protocol must 
also take into consideration the age and size of the patient as well as the ability of the scan to 
demonstrate the anatomy of interest.  It becomes obvious that image protocol optimization is not 
2 
 
a simple task and prescription requires a thorough knowledge of both diagnostic imaging and the 
risks of biologic effects due to ionizing radiation. 
The purpose of this study is to investigate the effective radiation dose associated with the Sirona 
GALILEOS® Comfort Cone Beam CT scanner using different scanning protocols.  An 
understanding of the effect of field of view (FOV), milliampere seconds (mAs), contrast and 
resolution (voxel size) on effective dose will aid the clinician in determining the optimum 
protocol for each patient and clinical question.  This study will focus on exposure while it is 
understood that image quality is also of importance and will require subsequent study. 
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BACKGROUND 
X-Radiation 
The x-ray was discovered in 1895 by Bavarian physicist Wilhelm Roentgen.
7
   Roentgen was 
experimenting with cathode rays using a vacuum tube, electrical current and screens that 
fluoresced when exposed to radiation when he noticed that screens on an adjacent table were 
fluorescing.  The screens were several feet away from the vacuum tube, a distance greater than 
cathode rays could travel.  He therefore concluded that there existed an unknown ray responsible 
for these findings and named it the x-ray due to its unknown properties.   Roentgen continued to 
experiment with x-rays eventually obtaining the first radiograph of the human body, that of his 
wife’s hand.7 
Dental Radiology: History 
Development 
With the discovery of the x-ray came interest in dental imaging.  In 1895 German dentist Otto 
Walkhoff obtained the first dental radiograph of his own mouth.
7
  Continued experimentation by 
several pioneers lead to application on live patients and the development of radiographic 
techniques.   Boston dentist William Rollins is accredited with the development of the first dental 
x-ray unit.
7
  He introduced interest in radiation protection recognizing the dangers of radiation.  
Unfortunately early pioneers were not aware of the associated dangers with many suffering the 
effects of overexposure to radiation. 
In 1913, William Coolidge developed the first hot-cathode x-ray tube.  It consisted of a high-
vacuum tube with a tungsten filament and serves as the prototype for all modern x-ray tubes.  
Victory X-Ray Corp. began manufacturing an x-ray machine with a small version of the x-ray 
tube within the head in 1923.  This design was later superseded by the variable kilovoltage 
machine in 1957 with introduction of the recessed long-beam tube head in 1966.
7
   
Initial dental x-ray packets were fabricated from glass photographic plates, wrapped in black 
paper and rubber.  Eastman Kodak Company began manufacturing pre-wrapped intraoral film in 
1913 with the first periapical packets available in 1920.  Subsequent improvements in film lead 
4 
 
to D-speed film in 1955, E-speed film in 1981 and F-speed film in 2000.  Current fast film 
requires less than 2% of the exposure required for that available in 1920.  
The modern era of digital dental radiography followed Dr. Francis Mouyen’s 1989 paper 
describing radiovisiography. 
8,9
  Multiple advantages have resulted in a shift toward digital 
imaging in dentistry including lower patient exposure, ability to transfer images between health 
care providers without degradation in image quality and a reduction in chemical, Silver and lead 
foil waste associated with analog imaging.
2
  Two main technologies exist, solid-state technology 
and photostimulable phosphor (PSP) technology.
2
  Solid state detectors function by collecting 
the charge produced by x-rays in a solid semiconducting material producing rapid image 
availability. 
2
  Subtypes include charge-coupled devices (CCD), complementary metal oxide 
semiconductors (CMOS) and flat panel detectors.  Photostimulable phosphor plates absorb 
energy from x-rays.  Stimulation by appropriate light leads to release of this energy in the form 
of visible light and subsequently quantified to measure the amount of x-ray energy absorbed.  
Dental Radiographic Techniques 
Intraoral 
Soon after the discovery of x-rays, dental radiographic techniques began to emerge.   Edmund 
Kells of New Orleans, with many significant contributions to radiology in North America, 
introduced the paralleling technique in 1896 while Weston Price introduced the bisecting 
technique in 1904.  This was later refined by Howard Raper when introducing the bite-wing 
technique in 1925.
7
  Franklin McCormack began use of the paralleling technique in 1920 and in 
1937 published a paper explaining the advantages to the long distance paralleling technique in 
minimizing distortion when compared to the bisecting technique.
7,10
  These advantages were 
realized when F. Gordon Fitzgerald introduced the long-cone paralleling technique in 1947. 
Extraoral 
Cephalometry 
Craniometry is described as the art of measuring the skulls of animals and has been documented 
for many centuries.
11
  It provided the foundation for cephalometry which involves measuring the 
head inclusive of soft tissue.  Documentation of skull form analysis dates back to Hippocrates 
5 
 
(460-357BC).
11
  Leonardo da Vinci (1452-1519) was one of earliest to apply the theory of head 
measurement, using a variety of lines relating to head landmarks in order to study human form.
11
  
Craniometry continued to develop in the following centuries during which the craniostat was 
developed in recognizing the importance of reproducibility and standardized methods.
11
 
In 1922, A.J. Pacini published a thesis entitled “Roentgen Ray Anthropometry of the Skull” in 
which he outlined a procedure for positioning and immobilizing a subjects head such that the 
median sagittal plane was parallel to the film.
12,13
  This was developed for anthropologic 
purposes.  It was not until 1931 that dentists Hofrath and Broadbent simultaneously published 
details on an apparatus, the ‘cephalostat’, used to position the heads of live patients in relation to 
the x-ray source and film such that the lateral cephalogram could be obtained.
11
  Subsequently, 
the art and science of cephalometrics developed gaining widespread acceptance for use in 
diagnosis, study of growth and development and the effects of treatment.
13
 
Conventional Tomography:  
Clinical demand for three-dimensional imaging lead to the development of conventional 
tomography with Polish radiologist Mayer first suggesting the idea in 1914.
14
  This technique is 
used to obtain an image of a select plane of tissue while blurring adjacent structures.
7
  In 
conventional film-based tomography, the x-ray tube and film are rigidly connected and 
synchronous movement around a fixed axis produces a sharp image layer (‘tomographic layer’) 
with adjacent structures outside the focal plane blurred.
2
   Several types of movement are 
possible including linear, circular, elliptic, hypocycloidal and spiral.
2
 
Panoramic  
While much utility was recognized in early intraoral techniques, the need for obtaining an 
unobstructed view of the maxilla, mandible and dentition was recognized.  In 1922, A.F. Zulauf 
patented the ‘panoramic x-ray apparatus”, describing a method where a narrow beam scanned 
both the upper and lower jaws.
15,16
  Hisatugu Numata of Japan was the first to expose a 
panoramic radiograph in 1933, using a device constructed for clinical examination termed 
“parabolic radiography” with the film placed lingual to the dentition.15  Yrjo Paatero of Finland, 
considered the ‘father of panoramic radiography’ experimented with slit beam and rotational 
6 
 
techniques.  He published several papers describing use of the technique in clinical 
practice.
7,15,17-20
 
Development of commercial equipment for panoramic radiography began with production of the 
Orthopantomograph by Palomex under the charge of Timo Nieminen in 1960.
15
  Increased 
clinical use resulted in progression to large-scale production.  Early models of commercial 
equipment were controlled by mechanical means.  The first publication on computed panoramic 
radiography was released by H. Kashima et al of Japan in 1985 with the first electronic system 
for rotational panoramic radiography reported by McDavid et al in 1991.
21-23
 
Conventional Computed Tomography (CT) 
Computed tomography has undergone continued development since first introduced for clinical 
application.  Related theory dates back to 1917 when mathematician J.H. Radon proved the 
distribution of an x-ray attenuating material in an object layer can be calculated if the integral 
values along many ray-lines passing through the same layer are known.
24
  The Radon transform 
provided the mathematical basis for image reconstruction from data associated with cross-
sectional scans.
24
     Physicist A.M. Cormack developed the first medical applications.
24
  From 
1957-1963 he developed a method of calculating radiation absorption distributions in the human 
body based on transmission measurements.  With these findings, Cormack proposed it was 
possible to display small absorption differences which would have application in imaging of soft 
tissues for planning radiation treatment of cancer.   
In 1972 English engineer G.N. Hounsfield found practical application for theory relating to 
tomography when he designed the first practical Computed Tomography (CT) scanner.
24
  He 
conducted the first clinical examinations with J. Ambrose in 1973 at British firm EMI.  Sixty 
EMI scanners were installed by 1974 with 18 companies offering CT equipment and more than 
10, 000 devices in use by 1980.
24
  In recognition of their significant work, Hounsfield and 
Cormack were both awarded the Nobel Prize for medicine in 1979.
24
 
The first-generation CT unit introduced in 1971 by EMI limited exposure to one pencil beam at a 
time, the x-ray source collimated to a beam measuring 3mm wide by 13mm long.  The x-ray 
source and detector both translated linearly to collect 160 measurements across the field after 
7 
 
which the tube and detector rotated one degree before collecting the subsequent set of 
measurements.
25
  The method of data collection resulted in limited efficiency in scan time, each 
scan taking approximately 4.5 minutes.  Image quality was therefore compromised as a result of 
patient motion. 
The second-generation CT scanner was developed with the intent of reducing total scan time and 
thus the effects of patient motion on image quality.  This was accomplished by introducing 
multiple (six) adjacent tilted pencil beams, each with an angle differing by one degree.  With this 
design, a scanner could translate across the patient but rotate at six degree intervals between sets 
of measurements.  In 1975 EMI introduced a scanner with 30 detectors capable of a complete 
slice scan in under 20 seconds, thus within the range of holdings one’s breath.25 
Further efficiency was accomplished in developing the third-generation CT scanner.  This design 
utilizes a broad fan shaped beam with many more detector cells arranged on an arc concentric to 
the source.   Unlike the previous generations, the source and detector remain coupled to each 
other as they rotate around the patient.  With such a design, the width of the entire object slice is 
irradiated by the source at any given time and no linear motion is required, ultimately reducing 
data acquisition time.  The third-generation scanner accounts for most modern scanners on the 
market today.
25
 
The fourth-generation scanner is designed using a stationary detector formed as a closed ring.  
The x-ray tube rotates around the patient with signals measured on a single detector at a given 
time.  A fan shaped beam is formed, however the apex is located at the detector rather than the 
source as found in the third-generation.  With this method each detector cell can be exposed to 
the x-ray source without attenuation at some point in the scan thus allowing for detector 
recalibration.  This method however requires a very large number of detectors and there is no 
practical method for post-patient collimation.  This requires an increased acceptance of scattered 
radiation and hence poorer contrast.  This design is less practical than the third-generation and it 
is for this reason the third-generation remains the dominant design in current clinical 
application.
25
 
8 
 
Cone Beam Computed Tomography (CBCT) 
Cone-beam computed tomography (CBCT) was introduced to the U.S. market in 2001 with the 
NewTom QR DVT 9000.
3,26
    In 2005 there were 4 main CBCT scanners reported in the 
literature with over 45 scanners offered by 20 manufacturers reported at the time of this 
writing.
27
   An overview of these scanners including technical specifications was provided by 
Nemtoi et al. 
27
  This growth in manufacturers has resulted from continued development and 
application of CBCT in both dentistry and general medical radiology.   
With CBCT, a diverging x-ray beam is limited by a circular or rectangular collimator to match 
the corresponding ‘flat panel’ detector or region of interest.  The conic source and detector rotate 
as a unit around the patient up to 360 degrees.  While rotating, a sequence of multiple two-
dimensional radiographic images is obtained.   ‘Back projection’ of all image data results in a 3D 
array  of three-dimensional volume elements referred to as ‘voxels’, which in general range in 
size from 0.07 to 0.40mm
3
.  Software is used to reconstruct and display this three-dimensional 
volume (Figure 1).
26
   
 
Figure 1: Sample Image, Sirona GALILEOS®  
 http://www.sirona.com/en/products/imaging-systems/GALILEOS®   
9 
 
Tissues and space within the region of interest vary in their x-ray attenuation values and voxels 
corresponding to their location are assigned relative gray-scale values.  Current units are capable 
of producing between approximately 4000 and 16, 000 shades of gray.  Since current computer 
monitors produce 256 shades of gray, software is used to overcome hardware limitations through 
use of ‘windowing’ and ‘leveling’ functions.   These functions allow the user to visualize 256 
shades of gray at a time distributed around the tissue attenuation values of interest.  After 
leveling is optimized for the tissues of interest, windowing is adjusted for contrast in a narrow 
band of attenuation values centred about the level value.
26
 
 
CBCT Applications  
Cone beam CT has applications in numerous branches of health care including angiography, 
surgical planning and intraoperative imaging, neuroradiology, image guided radiation therapy, 
otolaryngology and dentistry. 
28
 Applications for CBCT imaging in dentistry and orthodontics 
have continued to increase since introduction to the market.  In orthodontics applications include 
but are not limited to the three-dimensional assessment of impacted and ectopically erupting 
teeth, TMJ analysis, airway assessment, study of growth and development and treatment 
planning.  Suggested benefits in treatment planning include improved accuracy in cephalometric 
landmark identification and soft tissue profile, optimal assessment of location for Temporary 
Anchorage Device (TAD) placement and improved orthognathic surgery planning. 
29
   
Despite the reported benefits from manufacturers and practitioners, further evidence is required 
to justify the added burden of radiation exposure.  A systematic review conducted by van 
Vlijmen et al
29
 investigated the applications of CBCT imaging in orthodontics, evaluating the 
respective levels of evidence.  The authors identified 550 articles describing application in the 
use of TADs, cephalometry, combined orthodontic and surgical treatment, airway analysis, root 
resorption, tooth impactions and cleft lip and palate treatment.  Fifty articles met inclusion 
criteria.  No high-quality evidence was identified to support a significant benefit of CBCT use in 
orthodontics with only airway diagnoses suggesting improved value in comparison to two-
dimensional imaging techniques.
29
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While it is difficult to justify the routine use of CBCT imaging in dentistry and orthodontics, 
when three-dimensional imaging techniques are indicated CBCT techniques offer several 
advantages when compared to conventional CT scans of the head.   The most important 
advantage is a large reduction in patient dose.
3
  The reported effective dose of small and medium 
FOV units is 11-674µSv (median 61µSv) with large FOV units ranging from 30-1073µSv 
(median 87µSv).
6
   Reported effective dose from conventional CT is significantly higher, ranging 
from 1,320-3,324µSv for a mandibular scan and 1,031-1,420µSv for a maxillary scan.
6
  While 
CBCT doses are lower than standard CT doses, they are still significantly higher than other 
dental radiographic procedures.  Table 1 summarizes the effective dose associated with common 
two-dimensional radiographic techniques.
6
  The average background dose for all people on earth 
is approximately 2400 µSv per year, or 6.6 µSv per day.30 
 
Imaging Technique 
Effective Dose 
(µSv) 
Four posterior bitewings 5 
(digital PSP or F-speed film & rectangular collimation) 
 
Panoramic radiograph with charge-coupled device 3.0-24.3 
Cephalometric radiograph with PSP 5.1-5.6 
Full-mouth radiographs: 
 
PSP or F-speed film and rectangular collimation 34.9 
PSP or F-speed film and round collimation 170.7 
Table 1: Effective dose estimates for common dental radiographs
6
 
Cone-beam CT offers several non-dosimetric advantages when compared to conventional CT.  
Reduced size and cost increases clinical practicality outside the hospital setting.  The field of 
view (FOV) can often be reduced when desired with resulting reduction in exposure.  Other 
advantages include a reduction in scan time comparable to spiral MDCT minimizing effects of 
patient motion, reduction in metal artifacts as a result of algorithms designed by the 
manufacturer and display modes unique to maxillofacial imaging.
3
  
11 
 
The Biologic Effects of Radiation 
The biologic damage associated with radiation exposure is thought to be due to the direct action 
of radiation on DNA as well as the indirect action of free radicals produced in water.  Interaction 
of radiation with water produces free oxygen radicals that interact with other molecules causing 
damage to cell structures including DNA.
31
 
In humans, the biologic effects of radiation can be categorized as stochastic (i.e. random) or 
nonstochastic (i.e. non-random).   Nonstochastic effects were previously referred to as acute 
effects and in current terms ‘deterministic effects’.31  Deterministic effects are characterized by a 
threshold below which effects are not observed.  When the threshold is exceeded, the effects are 
seen and the magnitude increases with increased dose.  Such effects show a clear association 
with radiation exposure.
31
  Examples include erythema, loss of hair, cataracts, nausea, vomiting 
and depression of bone marrow cell division.
31
   
Stochastic effects were previously referred to as “late effects” as they usually occur years after 
exposure.   Certain tissues are at higher risk for stochastic effects, in particular those composed 
of cells with a high division rate, long dividing future and/or unspecialized type such as 
progenitor cells found in bone marrow.
31
  Such effects may or may not present in a given 
individual and are thus probabilistic in nature.
31
   The probability of stochastic effects increases 
with radiation dose but not necessarily the magnitude of the effect.  In contrast to nonstochastic 
effects, a threshold may not exist and there lacks a clear association between exposure and effect.  
Examples of stochastic effects include cancer and hereditary effects on the offspring of exposed 
individuals.
31
 
In oral and maxillofacial diagnostic imaging the primary concern is the risk for stochastic effects, 
namely radiation induced cancer.
2
  This is because the doses given are all well below the 
thresholds for deterministic effects.   Recognizing the risk associated with radiation exposure, 
prescription of dental and medical imaging must be done with diligence.  Dosimetry studies 
provide a means of estimating the biologic risk associated with radiation used in imaging or 
therapy.  Radiation dosimetry is the focus of this work. 
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Radiation Dosimetry 
Interaction of radiation with matter results in a transfer of energy to the atoms constituting 
tissue.
31
  Dosimetry is the determination of dose or the quantity of radiation exposure.
2
  Dose is 
described in terms of the energy absorbed per unit mass at a site of interest.  In clinical context, 
dosimetry ultimately provides estimates of the biologic effects of radiation from which 
appropriate therapeutic and diagnostic use can be determined.  Several methods are used to 
measure the quantitative effects of ionizing radiation with matter. 
Exposure   
When ionizing radiation interacts with matter ions are produced which have a net charge. 
Counting the resulting ions formed in air is the simplest method for measuring the quantitative 
effects of ionizing radiation.  This can be accomplished by using oppositely charged surfaces to 
attract and count the ions formed. The quantity exposure is a measure of radiation based on the 
ability to produce ionization in air under standard temperature and pressure conditions.  It 
provides a measure of the radiation present in an environment and is useful in survey meter 
measurements.
31
  Air kerma (‘kinetic energy released in matter’) is the SI unit of exposure and is 
expressed in units of dose, Gray [Gy= 1 Joule/kg] replacing the traditional unit of Roentgen (R).
2
 
Absorbed Dose 
While exposure provides a measure of the radiation present in the environment, it is of greater 
clinical importance to know the quantity of radiation actually absorbed by patients.  The 
‘absorbed dose’ describes the energy absorbed from any type of ionizing radiation per unit mass 
of any type of matter.
2,31
 
The SI unit for absorbed dose is also the Gy replacing the traditional unit of ‘rad’ (‘radiation 
absorbed dose’) which is equal to 1cGy.2  The absorbed dose is thus determined by the following 
equation: 
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Equivalent Dose  
Absorbed dose measures the physical energy absorbed but does not account for the fact that 
different types of radiation have a different potential in producing biological damage.  High 
linear energy transfer (LET) radiations such as high-energy protons are more damaging to tissue 
than lower LET radiations such as x-rays.
31
  The radiation weighting factor (WR) accounts for 
this relative biologic effect in human tissue and provides the basis for calculating the equivalent 
dose (HT).  The radiation weighting factor is dimensionless and therefore equivalent dose is 
represented in the same units as absorbed dose but may be described in the special unit of 
Sieverts (Sv). The corresponding definitions are as follows: 
 
 
The current radiation weighting factors as determined by the International Commission on 
Radiological Protection (ICRP) are summarized in Table 2. 
 
Type of Radiation WR 
Photons 1 
Electrons and muons 1 
Neutrons, energy: 
 
< 10 keV 5 
10 – 100 keV 10 
> 100 keV to 2MeV 20 
> 2 MeV to 20 MeV 10 
> 20 MeV 5 
Protons, other than recoil protons, E > 2 MeV 5 
Alpha particles, fission fragments, heavy nuclei 20 
Table 2: Radiation weighting factors recommended by ICRP
1
 
For the x-rays used in dental CBCT, the radiation weighting factor is 1.0; hence the values of 
Dose (in Gray) matches the values of Equivalent Dose (in Sv). 
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Effective Dose 
When an individual is exposed to radiation it may be to the whole body or in part.  Reducing the 
proportion of tissues exposed to radiation reduces the potential for biologic damage.  In addition, 
tissues differ in their radiosensitivity and risk for stochastic effects including cancer formation.
2
  
Effective dose (E) provides a means of estimating the biologic risk in humans exposed to 
radiation.  It allows for comparison of risk between partial exposures by representing such 
exposure as a full-body dose of equivalent detriment.
2
   Each tissue is assigned a tissue-
weighting factor (WT) (Table 3).  The effective dose is measured in units of Sieverts (Sv) and 
obtained through the sum of the products of average equivalent dose to each tissue and the 
associated tissue weighting factor.  This is summarized as follows: 
 
 
Organ 
Tissue Weighting 
Factor (WT) 
Gonads 0.08 
Red bone marrow 0.12 
Colon 0.12 
Lung 0.12 
Stomach 0.12 
Bladder 0.04 
Breast 0.12 
Liver 0.04 
Oesophagus 0.04 
Thyroid 0.04 
Skin 0.01 
Bone surface 0.01 
Brain 0.01 
Salivary Glands 0.01 
Remainder 0.12 
Table 3: Tissue weighting factors as recommended by ICRP (2007)
1
 
It is important to note that this assumes exposure to the full tissue volume.  If a given tissue is 
only exposed in part, it must also be taken into consideration when calculating the effective dose.  
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For example, in diagnostic radiology an image may only expose a fraction of the body’s skin.  
The relative proportion of skin exposed is taken into consideration by multiplying the fraction 
exposed by the skin's contribution to effective dose as follows: 
 
Experimental Dosimetry Methods 
There are several methods available for estimating the effective dose imparted by ionizing 
radiation all of which rely on computations or measurements in patient-like ‘phantoms’ and 
present with some limitations.
32
   The most common methods include organ dose, computed 
tomography dose index by volume (CTDIvol), CT air kerma-length product (PKL,CT), Air kerma-
area product (PKA),  Monte Carlo dose simulation programs,  entrance surface skin dose and 
energy imparted.  Organ dose measurements or calculations using and Monte Carlo simulations 
are common techniques employed in dental CBCT studies while CTDIvol measurement is most 
common in conventional CT dosimetry studies and warrants discussion. 
The computed tomography dose index by volume (CTDIvol) represents the mean absorbed dose 
in the examination volume.
32
  A 100mm pencil ionization chamber is used to measure the kerma-
length product (PKL) at the centre and periphery of standardized cylindrical phantoms with 
dimensions representing the head or body.  The weighted CTDI (CTDIW) is the sum of one-third 
of the value at the centre and two-thirds of the value at the periphery, corresponding to the 
average dose in a slice, assuming abutted but non-overlapping slices.  The CTDIvol is obtained by 
dividing the CTDIW by the pitch used for examination to account for overlapping slices using 
helical scanning.
32
  While this method has proven effective for single slice CT scanners with 
slice thicknesses not exceeding 10mm, several studies have demonstrated limited applications to 
thicker beam widths used in CBCT.
33,34
  As such, CTDIvol may present with limitations in 
characterizing the dose associated with CBCT images. 
Organ dose is based on estimates of the mean absorbed dose to different organs and tissues using 
dosimeters placed locally within a human anthropomorphic phantom.
32
  These phantoms are 
often composed of a natural human skeleton contained within a material radiologically 
equivalent to human soft tissue.  Accuracy in determining mean organ dose is limited given the 
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finite and limited number of dosimeters used.  Effective dose is obtained using the mean tissue 
doses and tissue weighting factors established by the ICRP.
1
  This method is the most 
predominant in studies relating to CBCT dosimetry in dentistry. 
Estimates of effective dose can also be obtained by mathematical models including Monte Carlo 
simulations.
32
  This technique uses knowledge of exposure parameters and beam quality together 
with a mathematical phantom of attenuation values to obtain an effective dose based on 
simulation of individual particle interactions and trajectories.
32
 
Dosimeters 
Organ dose measurement is the most common dosimetry method found in dental CBCT studies.  
The mean organ or tissue dose is determined by measuring the absorbed dose at a select number 
of sites within a given organ or tissue.  This is accomplished by use of dosimeters.  
Thermoluminescent (TL) dosimeters are historically the most common used in dental CBCT 
studies while newer optically stimulated luminescent (OSL) dosimeters are likely to become 
more common as they have proven accurate while offering efficient readouts with the option of 
being stored and reread at a later time. 
Luminescence describes a process by which energy absorbed by a semiconductor or insulator 
from ionizing radiation is subsequently released in the form of light (electromagnetic radiation) 
upon exposure to heat (thermoluminescence, TLD) or light (optically stimulated luminescence, 
OSL).
35
  This phenomenon is very useful in radiation dosimetry since the quantity of light 
emitted is proportional to the radiation dose absorbed by the material.
35
   
Many general models have been proposed to explain the mechanism of luminescence in select 
materials, one of which is the electronic band model (EBM).
35
  The theory suggests the presence 
of an energy band gap, or “forbidden band” separating two different energy bands, the valence 
and conduction bands.  Exposure to ionizing radiation results in excitation of electrons to the 
conduction band with resulting holes in the valence band.  These electrons and holes move 
within the material until they recombine or are captured by localized intermediate energy levels 
acting as traps.   The trapped charges can be stimulated back to the conduction band with 
subsequent de-excitation resulting in electron-hole recombination with resulting luminescence.   
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The intensity of luminescence is related to the trapped charge concentration and thus absorbed 
dose. 
36
 
For personal dosimetry, LiF:Mg,Ti (TLD-100) are the most common TL dosimeters used while 
other suitable materials include LiF:Mg,Cu,P, CaSO4:Dy and ZrO2. 
35
  Another material 
originally developed as a sensitive TLD material is Al2O3::C but its sensitivity to daylight instead 
resulted in the research leading to OSL development.
37
  Additional materials that followed for 
OSL include BeO, MgO, ABF fluorides, Ammonium salts and alkali halides.
37
  While 
thermoluminescent dosimeters have been used successfully for many decades, use of OSL 
dosimeters has become increasingly popular.  Table 4 summarizes the characteristics of both TL 
and OSL dosimeters. 
 
 
TLD OSLD 
Accuracy  
 
High 
(uncertainty ~3% for high 
doses)
35
 
High
35
 
(uncertainty 0.7-3.2%) 
36
 
Precision 
High
35
 
(reproducibility ~1.5%)
38
 
High
35
 
(reproducibility <1%)
38
  
Dose Linearity Supralinear >10Gy 
39
 Supralinear >3Gy
40
 
Reuse Reuseable
35
 Reuseable
38
 
Energy Dependence Correction Factor Required
41
 Correction Factor Required
41
 
Tissue Equivalence Tissue equivalent
35
 Nearly equivalent
37
 
Size ~ 3x3x1mm 
38
 ~ 7x7x0.5mm 
38
 
Directional Dependence None
35
 3-4% 
42
  None
38
 
Temperature Dependence 
Independent at ambient 
temperature
35
 
Independent
38
 
Fading Subject to fading
35
 
Wait time of 8min 
Slow fading day 17-38 
38,43
 
Readout Time 
No instant readout
35
   
Technique sensitive 
 ~ 8 min wait
38
 
 ~1min to read 
Table 4: Comparison of TLD and OSLD properties 
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CBCT Protocol Parameters 
When a radiological examination is required an imaging protocol is established.  A protocol is a 
set of exposure parameters (kV, mAs, FOV) defined by the clinician and developed to produce 
images of optimal quality while minimizing radiation burden to the patient.
2
  While standard 
protocols are often pre-programmed by CBCT manufacturers, parameters may be modified by 
the radiologist.  Scan parameters usually include scanning volume (field of view), voxel size 
(/resolution), the number of basis projections and exposure time. 
2
 
Clinical guidelines suggest that radiation dose be optimized in accordance with the ALARA 
principle.  The principle states that dose should be restricted to as low as reasonably achievable.
6
  
To accomplish this, the image should be restricted to a narrow field of view and produce image 
quality sufficient to answer the clinical question being addressed.  The quality of the image is 
dependent on multiple parameters such as desired spatial and contrast resolution determined by 
the clinician prior to exposure.  An understanding of the effects of these parameters on both 
image quality and dose is necessary to achieve an optimized protocol for each individual patient 
and associated clinical question. 
Field of View 
Field of View (FOV) is established by collimating the primary x-ray beam, limiting x-radiation 
to the region of interest thereby reducing effective dose by exposing only a subset of tissues and 
organs.
2
   Maximum field of view differs between CBCT units on the market, with small FOV 
machines beginning at 3x4x4mm (3D Accuitomo) and large FOV machines up to 20x20x20 cm 
(NewTom 3G).
44
   Many units offer multiple FOV settings which may for example be suitable 
for mandibular, maxillary or maxillofacial scans.  Restricting the field of view to the region of 
interest effectively reduces radiation dose and improves images quality by reducing scatter 
radiation.
2
     
Scan Time 
A CBCT scan is composed of a series of basis radiographic image projections.  In theory, a 
perfect reconstruction is possible if an infinite number of two-dimensional projections are 
obtained at an infinite number of angles.  This of course in not practical and instead a finite 
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number of basis images is selected by adjusting the frame rate while the x-ray tube rotates.
2
  
Increasing the number of basis projections increases image quality but patient exposure increases 
proportionately.
2
   
Exposure Time 
For optimal image quality the radiographic projections measured at the detector must be neither 
underexposed nor overexposed.  This number of x-rays at the imaging detector is determined by 
the number of x-rays produced, a product of milliamperage (mA) and exposure time (s).
2
  An 
increase in milliampere-seconds (mAs) may improve image quality but at the expense of 
increased patient radiation exposure.  An optimum image protocol will establish an exposure 
time for which image quality is diagnostic but patient exposure minimized. 
CBCT Voxel Size 
The voxel size varies between manufacturers with individual units often allowing user selection 
of voxel size.  A decrease in voxel size increases spatial resolution but results in increased 
radiation exposure for a fixed noise level.
2
 
Sirona GALILEOS® Parameters 
With the Sirona GALILEOS® CBCT scanner, the tube voltage is fixed at 85kV, with a current 
of 7mA (reduced to 5mA for 10mAs setting) and number of basis images (i.e. projections) is set 
at 200 by the manufacturer.  The user can establish multiple protocols by varying the mAs, field 
of view (FOV) and using high contrast or high resolution modes (voxel size 0.15 – 0.3mm).  The 
mAs options include 10, 14, 21, 28, 35 and 42 mAs (Figure 2).  The full field of view (FOV) 
measures 15x15x15cm spherically while the ‘upper jaw’ and ‘lower jaw’ settings collimate to a 
display volume with an approximate height of 8.5cm and therefore about 8.5 x 15 x 15 cm.
45
 
 
Figure 2: Available Exposure Settings for GALILEOS® Comfort 
Current is 7mA except for 10mAs for which current is 5mA  
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A review of the current literature was conducted in order to identify studies investigating 
dosimetry associated with the Sirona Galileos® CBCT scanner.  A search was completed using 
search terms ‘cone beam computed tomography’, ‘dosimetry’ and associated abbreviations and 
truncated terms.  Literature databases included PubMed, BIOSIS, EMBASE, CINAHL and 
Dissertations and Theses.  Studies matching initial search criteria were combined and reviewed 
by title and abstract.  Papers relevant to the research question were reviewed to determine the 
inclusion of the Sirona GALILEOS® Comfort CBCT scanner.  As of the writing of this thesis, 
only 3 such papers were identified. 
Ludlow and Ivanovic
46
 investigated the dosimetry associated with 8 dentoalveolar and 
maxillofacial CBCT units, including the Sirona GALILEOS®, as well as a 64-slice MDCT unit.  
Absorbed dose was measured for 24 select sites in the head and neck region using 
thermoluminescent dosimeter (TLD) chips and a radiation analog dosimetry (RANDO®) 
phantom.  Effective dose was calculated to be 70µSv for default exposure (full FOV, 21mAs) 
and 128µSv for maximum exposure (full FOV, 42mAs) based on 2007 ICRP
1
 tissue weighting 
factors.   
Pauwels et al
47
 determined the effective dose for a wide range of CBCT scanners and protocols 
including the GALILEOS® Comfort.
47
  Absorbed dose was measured using between 147 – 152 
TLD chips in anthropomorphic (ART) phantoms.    The effective dose for the Sirona 
GALILEOS® Comfort using a full FOV (15x15x15cm), 85kV and 28mAs was measured to be 
84 µSv.  Effective dose was also calculated based on 2007 ICRP
1
 tissue weighting factors.  The 
authors claim an improved accuracy as a result of an increased number and distribution of TL 
dosimeters throughout the phantom. 
Rottke et al
48
 evaluated the span of effective doses associated with ten different CBCT scanners 
including the GALILEOS® Comfort.  Absorbed dose was measured using TL dosimeters placed 
in 24 sites in a RANDO® phantom following the protocol of Ludlow.
46
  The effective dose span 
was established by measuring the doses for the lowest and highest exposure protocols.  The 
minimum exposure protocol using a full FOV, voxel size 0.15mm
3
 and current 7mA resulted in 
an effective dose of 51µSv.  Since the 10mAs exposure setting uses a reduced current of 5mA, it 
is assumed the authors set the exposure at 14mAs.  The maximum exposure protocol using a full 
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FOV, 0.3mm
3
 voxel size and 7mA (42mAs) current (/exposure) resulted in a measured effective 
dose of 95µSv.  Effective dose was again calculated based on 2007 ICRP
1
 tissue weighting 
factors.  
PURPOSE 
While the number of dosimetry studies relating to CBCT units used in dentistry continues to 
increase, few have reported findings associated with the Sirona GALILEOS® Comfort scanner 
for its full range of operation.  A review of the literature identified three such studies in which 
only a restricted number of protocols were investigated.   All protocols described were of full 
maxillomandibular scans.  With regard to exposure time, pooled data reveals effective dose 
associated with mAs settings of 14, 21, 28 and 42.  However, no single published study was 
identified comparing the effective dose for a range of exposure and FOV settings. 
The purpose of this thesis is to determine and compare the dosimetry associated with different 
scanning protocols available with the Sirona GALILEOS® Comfort CBCT scanner.  This 
information should assist in determining the optimal scanning protocol for each patient when 
combined with knowledge of respective effects on image quality. 
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MATERIALS AND METHODS 
Absorbed dose was measured using optically stimulated luminescent (OSL) dosimeters placed 
within a single, modified, male tissue-equivalent Alderson RANDO® phantom.   
Dosimeters 
Absorbed dose was measured at established sites using InLight
®
 nanoDot
™
 OSL dosimeters 
(Landauer, Glenwood, Ill).  OSL dosimeters offer a wide operating energy range, efficient 
readings and reanalysis capabilities with minimal angular and energy dependence.
38
 
In total, 27 OSL dosimeters were used throughout the study.  All dosimeters were calibrated 
using a Therapax HF150 superficial radiation therapy x-ray unit (Pantak, East Haven, CT) with a 
1.1mm Al +0.3mm Cu filter.  This filter allowed for production of a beam quality similar to that 
of the GALILEOS® Comfort confirmed by measurement of the respective Half Value Layer 
(HVL).  The Therapax unit allows user control over kVp, mA, exposure time and source to 
object distance.  Groups of OSL dosimeters not exceeding the beam field were positioned flat on 
a Polymethyl methacrylate (PMMA) block 140mm in height (Figure 3).  This platform 
approximated the dimensions of the human phantom to account for similar amounts of 
backscatter radiation.  The OSL dosimeters were exposed at fixed dose intervals and read until 
the cumulative count exceeded the maximum count of the OSL dosimeters used for phantom 
protocols. Each OSLD was read using a microstar OSLD reader (Landauer, Glenwood, Ill), 
taken as the average of three repeated readings.    Each exposure was measured under identical 
conditions using a Farmer Chamber and Capintec 192 Digital Exposure Meter (Capintec, 
Ramsay NJ) with calibration traceable to national standards.  Respective calibration curves were 
established to characterize each individual OSLD and obtain corrected dose from each OSLD 
reading.  Appropriate adjustments were made for room temperature and pressure. 
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Figure 3: Therapax HF 150  
1.1mm Al + 0.3mm Cu filter, Farmer Chamber & PMMA background 
 
Phantom 
The head and neck segment of the RANDO® phantom consists of 10 sections, each with 
predrilled holes designed to accommodate thermoluminescent dosimeters (TLDs).  In order to 
place OSL dosimeters, five PMMA templates (Figure 4) 2.15mm thick were fabricated and 
placed superior to sections three, four, six, seven and nine (Figure 5).  In diagnostic radiology, 
PMMA is the most tissue equivalent material used.
49
  Square holes were placed in each template 
large enough to accommodate OSL dosimeters at anatomical landmarks without allowing 
movement. 
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Figure 4: PMMA template for OSLD placement 
 
Figure 5: RANDO® phantom with PMMA templates in place 
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Anatomic Landmarks 
Twenty six sites were measured corresponding to the 24 anatomical positions described by 
Ludlow (Table 5).
50
    Two sites each were established for the left and right mandibular body.  
Due to difficulty approximating the centre of the body, one site was positioned superior to and 
another inferior to the mandibular body with the average absorbed dose representing that of the 
mandibular body.  An additional OSLD was used to measure background radiation and was 
present beside the operator during acquisition and remained with the other dosimeters during 
transport.  
 
Anatomic Location 
OSLD 
Number 
OSLD ID 
Calvarium anterior 1 34151D 
Calvarium left 2 42477T 
Calvarium posterior 3 42098X 
Midbrain 4 44986I 
Pituitary 5 46848I 
Right orbit 6 29436W 
Left orbit 7 48908I 
Right lens of eye 8 41606Z 
Left Lens of eye 9 46757L 
Right cheek 10 409410 
Right parotid 11 27592Y 
Left parotid 12 37841X 
Right ramus 13 26177Z 
Left ramus 14 32758P 
Centre cervical spine 15 31835W 
Left back of neck 16 44131D 
Right mandible body upper 17 45032C 
Right mandible body lower 18 35299O 
Left mandible body upper 19 32817T 
Left mandible body lower 20 48629K 
Right submandibular gland 21 31657U 
Left submandibular gland 22 32871Z 
Centre sublingual gland 23 28791V 
Midline thyroid 24 46970B 
Thyroid surface - left 25 294126 
Esophagus 26 35015A 
Background 27 321268 
Table 5: Anatomic sites for dosimeter placement 
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Each phantom is constructed of a natural human skeleton cast inside a standard mold composed 
of a material radiologically simulating soft tissue.    Initial images of the phantom revealed 
discrepancies between soft tissue contours of the head and neck and the underlying skeleton 
(Figure 6).  Dosimeter sites for skeletal and internal soft tissue landmarks were established in 
relation to the skeleton while surface landmarks were established with respect to soft tissue sites 
on the RANDO® phantom.   Surface landmarks were marked with tape over which OSL 
dosimeters were centred for each protocol. 
 
 
Figure 6: Relationship of hard and soft tissue in RANDO® phantom 
 
With the PMMA templates in place, lead foil from intraoral radiograph packets was placed in 
each internal OSLD location and a 3D scan completed.  The reconstructed image was examined 
to confirm acceptable location of each internal landmark (Figure 7). 
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Figure 7:  Lateral Cephalometric view with lead foil at OSLD locations  
 
Phantom Orientation 
The RANDO® phantom was oriented with the occlusal plane parallel to the scan plane, the 
outline of the soft tissue chin and nose visible and both inferior and posterior borders of the 
mandible superimposed.  After an acceptable setup was obtained, the Volume Control Head 
mount supplied for the Sirona GALILEOS® was modified with three wires extending from 
custom acrylic attachments (Figure 8).  The tips of each wire corresponded to surface points on 
the phantom marked with tape.  This allowed for reproduction of the setup between protocols.  
The image from each protocol was examined and deemed acceptable if the ‘rotation’ and ‘tilt’ 
settings required to establish optimal superimposition of the right and left borders of the 
mandible did not exceed ±1 unit of rotation or tilt correction (Figure 9). 
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Figure 8: Modified mount for setup reproduction 
 
 
Figure 9: 'Tilt' and 'Rotation', confirming setup reproduced 
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Protocols 
With three fields of view, six mAs and two contrast and resolution settings available, a total of 
72 protocols are possible with the Sirona Galileos® Comfort CBCT scanner.  Of these 72 
protocols a total of 12 were investigated, chosen as a representative sample of those available.  In 
choosing these 12 protocols, those most commonly used are included and sufficient protocols 
were selected to allow changes in one parameter while keeping the remaining 3 unchanged.  The 
protocols selected are summarized in Table 6.  Protocol #1 (Full FOV 42mAs VO1HC) was 
repeated on three separate occasions to investigate variability in effective dose calculations 
between repeated protocols. 
 
Protocol 
# 
Field of 
View 
mAs Resolution Contrast 
1 Mandibular 14 VO1  High  
2 Mandibular 28 VO1 High  
3 Mandibular 42 VO1 High  
     
4 Maxillary 14 VO1 High  
5 Maxillary 28 VO1 High  
6 Maxillary 42 VO1 High  
     
7 Full 14 VO1 High  
8 Full 28 VO1 High  
9 Full 42 VO1  High  
10 Full 42 VO1 Normal 
11 Full 42 VO2  High  
12 Full 42 VO2 Normal 
 
Table 6: Summary of protocols investigated 
 
Prior to each protocol, room temperature and pressure were measured using a Traceable Digital 
Workstation Barometer (VWR International, Mississauga Ont.).  A certificate is provided from 
VO1 = High Resolution Setting 
VO2 = Standard Resolution Setting 
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an ISO 17025 calibration laboratory accredited by A2LA to indicate instrument traceability to 
standards provided by the National Institute of Standards and Technology. 
Each scanning protocol was repeated three times prior to removing the OSL dosimeters from the 
phantom to minimize the contribution of noise to absorbed dose.  Absorbed dose was thus 
obtained by dividing the dose measured by three.   At least 15 minutes was ensured between 
scanning and reading the dosimeters as suggested by the manufacturer.  This allows low-level, 
non-dosimetric electron traps to stabilize.
38
   
The dosimeters were read using a microstar OSLD reader (Landauer, Glenwwod, Ill) taking the 
mean value of three subsequent readings.  They were annealed using a high intensity light source 
(Figure 10) after no more than three subsequent protocols to minimize the increase in 
measurement uncertainty associated with dose accumulation. 
 
Figure 10: High intensity light source to anneal OSL dosimeters 
Dosimeter counts were entered into a spreadsheet and absorbed dose determined by means of 
applying individual calibration curves.  Effective dose was calculated using the mean absorbed 
dose to the individual tissues and organs, applying the corresponding 2007 ICRP
1
 tissue 
weighting factors and correcting for the fractional volume of tissue irradiated.  The fraction of 
tissue irradiated was determined by following that outlined by Ludlow and Ivanovic.
46
  A 
correction factor of 2.76 was applied for bone surface dose relative to bone marrow dose based 
31 
 
on the ratio of mass energy absorption coefficients for bone and muscle. The ratio is energy 
dependent and was chosen for a kVp of 85 and Half Value Layer (HVL) of 7mm of Aluminum.
51
  
However a correction for enhanced backscatter from bone was not applied.
52
  Table 7 lists the 
dosimeters used to sample each tissue and summarizes the respective fraction of tissue irradiated 
and tissue weighting factors.  For those tissues located outside of the head and neck, absorbed 
dose was assumed to be negligible.  
 
 
Tissue/Organ 
ID of OSLDs Used to 
Sample Tissue 
Fraction of 
Tissue 
Irradiated (%) 
Tissue Weighting Factor 
(WT) 
Red bone marrow  16.5 0.12 
     Mandible 13, 14, 17-20 1.3  
     Calvaria 1, 2, 3 11.8  
     Cervical Spine 15 3.4  
Oesophagus 26 10 0.04 
Thyroid 24, 25 100 0.04 
Skin 8, 9, 10, 16 5 0.01 
Bone surface  16.5 0.01 
     Mandible 13, 14, 17-20 1.3  
     Calvaria 1, 2, 3 11.8  
     Cervical Spine 15 3.4 
 
Brain 4,5 100 0.01 
Salivary Glands 11, 17-23, 12, 21, 22, 23 100 0.01 
Remainder   0.12 
     Lymphatic nodes 11-15, 17-24, 26 6  
     Muscle 11-15, 17-24, 26 6  
     Extrathoracic Airway 6, 7, 11-15, 17-24, 26 100  
     Oral mucosa 11-14, 17-23 100  
Gonads  0 0.08 
Colon  0 0.12 
Lung  0 0.12 
Stomach  0 0.12 
Bladder  0 0.04 
Breast  0 0.12 
Liver  0 0.04 
Table 7: Percentage tissue irradiated, tissue weighting factor and OSLD sample for each 
tissue/organ 
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RESULTS 
A summary of the effective dose associated with each protocol is presented in Table 8, each 
based on 2007 ICRP
1
 tissue weighting factors (Table 3).    The effective dose span ranged from 
36 µSv for a maxillary scan at 14mAs to 142 µSv for a full maxillomandibular scan at 42mAs.  
This is equivalent to between 5 and 22 days of per capita background radiation based on a world 
annual average of 2400 µSv.
30
 
 
Protocol 
Field of 
View 
mAs Contrast Resolution 
Effective Dose (µSv) 
(ICRP 2007)
1
 
Days per capita 
background 
(2007)* 
1 Mandibular 14 High High 37 6 
2 Mandibular 28 High High 74 11 
3 Mandibular 42 High High 107 6 
4 Maxillary 14 High High 36 5 
5 Maxillary 28 High High 69 11 
6 Maxillary 42 High High 100 15 
7 Full 14 High High 48 7 
8 Full 28 High High 95 14 
9 Full 42 High High 142 22 
9 Full 42 High High 140 21 
9 Full 42 High High 141 22 
10 Full 42 High Standard 142 22 
11 Full 42 Normal High 142 22 
12 Full 42 Normal Standard 140 21 
Table 8: Effective dose calculations for protocols completed 
*assuming world average of 2400µSv/year30 
The full maxillomandibular scan at 42mAs, high contrast and high resolution was repeated on 
three separate occasions (Protocol #9).  The effective dose calculated for each was 140, 141 and 
142 µSv.   Minimal variability in effective dose was associated with dosimeter placement and 
phantom orientation between protocols. 
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Collimating for a maxillary or mandibular scan resulted in a reduced effective dose relative to a 
full maxillomandibular scan.  Table 9 shows the effective dose for both maxillary and 
mandibular scans as a percentage of a full scan for each  mAs investigated.  All scans were high 
resolution and high contrast.  The effective dose associated with a full maxillomandibular scan is 
reduced on average by 28% when collimated for a maxillary scan and 23% when collimated for a 
mandibular scan.  This exceeds the 15% approximation reported by Sirona.
45
 
Field of 
View 
14mAs 28mAs 42mAs Mean 
Maxillary 74% 73% 70% 72% 
Mandibular 78% 78% 76% 77% 
Table 9: Effective dose of collimated scans 
 as a percentage of full maxillomandibular scan dose by mAs 
Figure 11 depicts the changes in effective dose with increasing mAs for maxillary, mandibular 
and full fields of view.  All scans were at high resolution and contrast.  Both maxillary and 
mandibular scans show a similar effective dose reduction relative to a full scan throughout the 
range of mAs settings.  This difference increases in magnitude with increasing mAs.  An 
increase in mAs results in a linear and proportional increase in effective dose for all fields of 
view. 
 
Figure 11: Effective Dose vs mAs 
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The mean equivalent dose to individual organs and tissues is summarized in Table 10. Table 11 
compares the equivalent doses for maxillary scans as a percentage of the equivalent doses for 
mandibular scans, taking the mean of 14, 28 and 42 mAs percentages.    While the effective 
doses for maxillary and mandibular scans are similar, the distribution of equivalent doses to the 
tissues differs.   For a maxillary scan, the equivalent dose to the brain is on average 298% of that 
for a mandibular scan and similarly 146% for skin and 140% for bone marrow. 
 
Protocol 
Bone 
Marrow 
Thyroi
d 
Esophagu
s 
Skin 
Bone 
Surface 
Salivary 
Glands 
Brain 
Lymphati
c Nodes 
Extrathoraci
c Region 
Muscle 
Oral 
Mucosa 
        Remainder Tissues 
Full 14mAs VO1HC 73 112 4 36 202 1104 447 889 856 889 1020 
Full 28mAs VO1HC 139 233 19 67 382 2225 776 1793 1719 1793 2042 
Full 42mAs VO1HC #1 208 335 32 98 573 3372 1150 2683 2582 2683 3058 
Full 42mAs VO1HC #2 206 351 30 100 568 3296 1108 2638 2536 2638 3005 
Full 42mAs VO1HC #3 211 327 33 102 583 3328 1144 2665 2557 2665 3025 
Full 42mAs VO1NC 201 359 31 102 555 3418 1109 2659 2559 2659 3028 
Full 42mAs VO2HC 211 322 30 105 582 3363 1157 2686 2584 2686 3065 
Full 42mAs VO2 NC 206 326 29 105 567 3320 1123 2646 2546 2646 3021 
Max 14mAs VO1HC 69 45 0 29 189 707 442 632 630 632 710 
Max 28mAs VO1HC 131 97 5 62 361 1399 785 1242 1239 1242 1383 
Max 42mAs VO1HC 185 145 10 93 511 2016 1090 1793 1794 1793 1989 
Mand 14mAs VO1HC 51 90 3 25 139 956 196 782 701 782 909 
Mand 28mAs VO1HC 94 204 13 41 260 1966 257 1588 1413 1588 1830 
Mand 42mAs VO1HC 129 299 24 56 355 2917 301 2327 2068 2327 2687 
Table 10: Equivalent dose (µSv) to tissues/organs 
 
 
 
 
Bone Marrow Thyroid Esophagus Skin 
Bone 
Surface 
Salivary 
Glands 
Brain 
Lymphatic 
Nodes 
Extrathoracic 
Region 
Muscle 
Oral 
Mucosa 
140% 49% 27% 146% 140% 71% 298% 79% 88% 79% 76% 
Table 11: Equivalent doses for maxillary scan as a percentage of equivalent doses for 
mandibular scan (taken as mean of percentages for 14, 28 and 42 mAs) 
 
VO1 = High Resolution 
VO2 = Standard Resolution 
HC = High Contrast 
NC = Normal Contrast 
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Table 12 summarizes the effective dose for protocols where contrast and resolution were 
changed while field of view and mAs were kept at full maxillomandibular and 42 respectively.  
Effective dose was within 2 µSv for these protocols suggesting that changes in contrast and/or 
resolution have little if any impact on effective dose. 
 
Protocol 
Field of 
View 
mAs Contrast Resolution Effective Dose (µSv) 
(ICRP 2007)
1
 
Days per capita 
background (2007)* 
9 Full 42 High High 141 22 
10 Full 42 High Standard 142 22 
11 Full 42 Normal High 142 22 
12 Full 42 Normal Standard 140 21 
Table 12: Effect of resolution and contrast on dose 
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DISCUSSION 
The mean effective dose calculated for the maximum exposure (maxillomandibular scan, 
42mAs, high contrast, high resolution) was 141 µSv.  This compares with previous findings, 
Ludlow and Ivanovic
46
 who reported 128 µSv and Rottke et al
48
 who reported 95 µSv.  The 
effective dose calculated for a maxillomandibular scan at 28mAs (high contrast, high resolution) 
was 95 µSv compared to 84µSv reported by Pauwels et al.
47
  All reports are based on 2007 
ICRP
1
 tissue weighting factors. It is important when making comparisons between studies that 
the same weighting factors are used.  In general, effective dose based on 1990 ICRP tissue 
weighting factors is significantly reduced relative to 2007 due to the increased weighting factors 
for salivary gland tissue  and brain introduced in 2007. 
During this study, calibration curves for each OSLD were initially established by two methods.  
The method used in this study simulated conditions of surface dosimeters  (‘free in air’ with 
PMMA background) while the other simulated conditions of dosimeters placed internally by 
placing them under 5cm of PMMA.  A 5cm PMMA barrier was chosen when it was estimated 
that the beam was attenuated by an average of 5cm of phantom tissue prior to reaching the 
internal dosimeters.  The ‘free in air’ method with a PMMA background was chosen for the 
definitive calibration method in order to minimize the risk of underestimating effective dose.  
Preliminary calculations using ‘in plastic’ calibration curves determined an effective dose of 102 
µSv for a full scan at 42 mAs as compared to the definitive calculation of 141 µSv using ‘in air’ 
calibration. 
The discrepancy between effective dose calculations based on ‘free in air’ and ‘in plastic 
(PMMA)’ calibration curves reveals the importance of the calibration process in obtaining 
accurate effective dose estimates.   Ludlow and Ivanovic
46
  reported the use of 
thermoluminescent dosimeters that were precalibrated and analyzed by the supplier Lindauer 
(Glenwood, IL).  It is unclear under what conditions respective calibration curves were 
established.  Pauwels et al
47
 reported the use of two types of TLDs, one type calibrated free in 
air, the other by calibrating internal calibration dosimeters for each experiment.   Rottke et al
48
 
calibrated each TLD to obtain individual calibration factors.  Those with calibration factors 
outside two standard deviations were excluded while an average calibration factor was used for 
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effective dose calculation.  There is no mention whether calibration was completed ‘free in air’ 
or under different conditions. 
An additional property that is significant when using dosimeters is their angular dependence.  It 
is possible that the orientation of a dosimeter to the primary beam affects the dose measured.   
Thermoluminescent dosimeters are directionally independent.
35
  There is conflicting evidence 
with regard to the angular dependence of OSL dosimeters with a study by Jursinic
38
 finding no 
angular dependence when exposed to 50 cGy of 6 MV x-rays while Kerns et al
42
 report a 3-4% 
variation in OSLD response with variation in dosimeter orientation relative to a 6 and 18MV 
photon beam.  It may be ideal to calibrate the dosimeters at their defined positions in the 
RANDO® phantom to circumvent the issues of orientation and ‘in air’ versus ‘in plastic’ 
calibration.  However, there is no means to acquire standardized reference dose measurements at 
these sites using an ion chamber. 
This study aimed to identify the effect of each parameter on effective dose.  A reproducible set-
up is of great importance such that comparisons can be made between different protocols.  Once 
an acceptable position of the phantom was obtained, a modified Volume Control Head Mount 
was used to reproduce positioning based on three surface points.  After each protocol the ‘tilt’ 
and ‘rotation’ settings were modified to obtain optimal superimposition of the posterior and 
inferior borders of the mandible.  A set-up was deemed to be adequately reproduced if these 
settings did not deviate more than ±1 tilt or rotation correction unit.  This range was established 
arbitrarily prior to the study.  It is unclear if the tilt and rotations settings correspond to a given 
number of degrees but it was observed that modifying the tilt or rotation ±1 corresponded to 
relatively little movement of the image.  Using the modified head mount proved successful with 
every protocol adequately reproducing the original.  To investigate the reproducibility of 
effective dose measurement, a maxillomandibular protocol with maximum exposure (42mAs, 
high contrast, high resolution) was repeated on three separate occasions. The effective dose was 
very similar measuring 140, 141 and 142 µSv. 
Thermoluminescent dosimeters have been used with success for many decades and account for 
the majority of dosimeters used in organ dose phantom studies in dentistry.  As a result, most 
phantoms in use are prepared with predrilled holes to accommodate TL dosimeters.  These are 
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often cylindrical and smaller in size than the InLight
®
 nanoDot
™
 OSL dosimeter (Landauer, 
Glenwood, Ill) used in this study.   Optically stimulated luminescent dosimeters were chosen for 
use in this study as they were already in established use in our associated clinical cancer therapy 
facility.  They offer acceptable accuracy and precision, less dependence on technique and 
operator and less concerns with respect to signal fading between radiation exposure and readout.  
A review of the literature revealed only one dental CBCT dosimetry study using OSL 
dosimeters.  Al Najjar et al
53
 compared the adult and child radiation equivalent dose from two 
dental CBCT units.   They used OSL dosimeters of unspecified type and head phantoms 
manufactured specifically to accommodate OSL dosimeters.  Comparing results between studies 
can be difficult due to differences in phantom and dosimeters used.  In this study, a RANDO® 
phantom previously prepared for use with TL dosimeters was modified to accommodate OSL 
dosimeters using five 2.15mm thick PMMA templates designed to fit between the phantom 
sections.  This effectively increases the dimensions of the phantom by approximately 11mm and 
could therefore affect absorbed doses by displacing OSL dosimeters located more superiorly and 
inferiorly further from the primary beam.  While PMMA is commonly used in dosimetry studies 
due to its tissue equivalent properties, its attenuation value may differ from that of the RANDO® 
phantom.   
An advantage of TL dosimeters for the phantom used is the potential to place the dosimeters 
anywhere within the phantom.  With the modified phantom, OSL dosimeter placement was 
restricted to the PMMA templates between phantom sections.  Initial images revealed that the 
skull was not well related to the soft tissue contours with the hard tissue chin displaced quite 
superiorly.  Each phantom is composed of a natural human skull cast inside a standard soft tissue 
mold and thus each phantom is unique.  Variations in the natural skulls between phantoms could 
affect the appropriate section for dosimeter placement and the relationship of tissues and 
structures to the primary beam.  In this study we chose to place internal dosimeters according to 
hard tissue references and external dosimeters according to soft tissue landmarks.  Accuracy in 
the spatial relationship between internal and external dosimeters was limited by the phantom 
anatomy.  The phantom was oriented with the goal of maximizing hard tissue structures and soft 
tissue contours of interest.  It is possible that superior and inferior structures were further 
displaced from the primary beam due to the anatomy of the phantom.  An image obtained with 
lead foil in place of dosimeters revealed reasonable approximation to the tissues and structures of 
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interest.  While the phantom anatomy and need for modification to accommodate OSL 
dosimeters does present some limitations, comparisons between protocols within the study 
remain valid. 
Optically stimulated luminescent dosimeters were selected for this study.  They provide a more 
efficient and less technique sensitive reading than TL dosimeters and not subject to the same 
degree of fading.   They have good accuracy and precision and are suitable for dosimetry studies.  
A logistical advantage of OSL dosimeters is the potential for incremental use where, unlike 
TLDs, minimal charge is lost during analysis (0.04-0.25%).
54
  The manufacturer discourages 
continued incremental use since a supralinear dose response is noted when accumulated dose 
exceeds 300cGy and the uncertainty of measurements can increase from 2% to as much as 4%.  
A 100 cGy dose corresponds to an approximate signal of 130 000 counts with the OSL dosimeter 
used.
38
  For logistical reasons, OSL dosimeters were used for incremental measures with up to 
three protocols measured prior to annealing for re-use.  The accumulated signal did not exceed 
100 000 counts and therefore well within the range of a linear dose response. 
One comparison of interest is the effect of resolution and contrast settings on effective dose.  
With the Sirona GALILEOS® Comfort CBCT scanner, the user has the options of high or 
standard contrast and resolution settings.  A full maxillomandibular scan was completed at 
42mAs for all 4 resolution and contrast combinations.   There was no significant difference in 
effective dose between the four protocols.  The manufacturer reports that both high and standard 
resolution options produce a data volume set with 512 x 512 x 512 voxels.  The high-resolution 
secondary reconstruction can be generated by the software only if the high-resolution setting is 
selected.  Specific information regarding the difference between high and standard settings for 
resolution and contrast proved difficult to obtain.  Limited information available suggested that 
pixel binning occurs if the high-resolution setting is selected thus transferring data with a voxel 
size of 0.3mm but maintaining the capability of reconstructing an image with 0.15mm voxel size 
post acquisition.  The standard resolution does not maintain this capability but may as a result 
allow for faster data transfer.  These results suggest that there is little benefit in selecting the 
standard resolution setting and contrast settings should be chosen based on optimizing the tissues 
of interest.  It is likely the same projection set is acquired regardless of the contrast and 
resolution software settings selected prior to image acquisition. 
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An important clinical decision when obtaining a CBCT image is selecting the field of view as 
additional information can be obtained with a larger field of view but at the expense of increased 
patient exposure.  This decision will be based on potential structures of clinical interest and the 
associated dose incurred when acquiring the image.  The results of this study suggest that 
collimating to a maxillary or mandibular scan results in a reduction in effective dose of 
approximately 28% and 23% respectively, this exceeds the approximate 15% reported by the 
manufacturer.  It should be noted that no modifications were made to the percentage of tissue 
irradiated when calculating the effective dose for partial scans.  It could be argued that respective 
reductions should be made which could result in additional reduction in effective dose when 
partial scans are selected.  A review of previous literature revealed only one study adjusting 
fraction of tissue irradiated for partial scans with adjustments based on the opinion of the local 
radiologist.
55
  No modification to the fraction of tissue irradiated was elected as it was observed 
that all dosimeters registered a significant dose for partial scans.  This ‘conservative’ approach 
reduces the risk of under reporting the effective dose but may as a result neglect to report the full 
benefit in dose reduction when selecting a collimated protocol.  Based on these findings it is 
apparent a moderate reduction in effective dose is realized when selecting a partial scan.  
However, if structures present on a full scan are omitted by collimation and may be of interest in 
the future, consideration towards a full scan is justified as the cumulative dose of two separate 
partial scans is likely to exceed that of a full scan. 
The primary aim of this study was to investigate the impact different parameters had on effective 
dose.  Ideally each of the 72 potential protocols would be investigated individually.  This would 
allow more robust statistical analysis of linearity when comparing effective dose with changes in 
mAs.  In addition, changes in contrast and resolution settings were investigated only for full 
maxillomandibular scans at 42mAs.  While a similar data acquisition process is likely for the 
remaining field of views and mAs settings, this cannot not be concluded with certainty. 
Effective dose is important when determining the optimum scanning protocol for an individual 
patient and clinical question.  The information provided by this study is useful in understanding 
the relative effects each parameter has on effective dose.  It is important to understand that 
establishing an optimum protocol must also consider image quality.  Collimation reduces the 
amount of structures visible on the image while changes in mAs, contrast and resolution can and 
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often do impact the image quality.  Such changes may or may not impact diagnosis. Future study 
of the impact of the same parameters on image quality (e.g. standard tests of spatial and contrast 
resolution) would provide equally important information in determining optimum scanning 
protocols using the Sirona Galileos® CBCT scanner.  
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SUMMARY 
The aim of this study was to measure and compare the effective dose associated with a sample of 
protocols available using the Sirona GALILEOS® Comfort CBCT scanner.  With this unit the 
tube voltage and number of basis projections are set by the manufacturer to 85kVp and 200 
respectively.  The user can establish a protocol by selecting between mAs, contrast, resolution 
and collimation settings.  This study investigated 12 protocols with modifications to all four 
parameters.   
Results revealed a dose span of 48 µSv to 142 µSv for a full maxillomandibular scan, relatively 
low when compared to conventional CT units but significantly higher than panoramic and lateral 
cephalometric exposures.   Effective dose varied  linearly with mAs while contrast and 
resolutions settings had little impact on effective dose for this scanner.   A moderate reduction in 
effective dose can be realized when collimating for a partial scan.   
Cone beam computed tomography can provide significant diagnostic value when prescribed 
appropriately.  Further evidence is needed to clarify when the clinical benefit justifies the burden 
of additional radiation exposure.  When a CBCT image is justified, the results of this study will 
assist the clinician in determining the optimum protocol for each patient when considered in the 
context of diagnostic or treatment planning applications. 
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CONCLUSIONS 
This study demonstrates the importance of setting individualized patient exposure protocols in 
order to minimize patient dose from ionizing radiation used for diagnostic or treatment planning 
tasks.  This can observation is supported by the following conclusions: 
The highest mean effective dose calculated was for a full maxillomandibular scan at maximum  
(42) mAs was 141 µSv based on  2007 ICRP
1
 tissue weighting factors.    The lowest mean 
effective dose was 36 µSv for a maxillary scan at 14mAs. 
1. Collimating to obtain a maxillary or mandibular scan decreased effective dose by 
approximately 28% and 23% respectively. 
2. Changes to mAs and beam collimation have a significant influence on effective dose. 
3. Changes in contrast and resolution software settings have little impact on effective dose 
with the Sirona GALILEOS® CBCT scanner.  
4. Effective dose varies linearly with mAs. 
This work has established a comprehensive baseline of dosimetric findings for subsequent 
comparison of image quality indicators in phantoms and clinical images obtained by each 
Galileos Comfort protocol.  The goal remains to optimize radiation exposure to “as low as is 
reasonably achievable”, while achieving the intended clinical benefit to the patient. 
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Appendix A:  Average OSLD Counts - Full Scan, 42mAs, HC/HR 
 
  Baseline #1 
 
#2 
 
#3  
Anatomic Location OSLD ID Avg Reading Avg Reading Net Count/3 Avg  Reading Net Count/3 Avg Reading Net Count/3 
Calvarium anterior 34151D 25 4537 1504 9021 1495 13277 1419 
Calvarium left 42477T 22 2190 723 4198 669 6495 766 
Calvarium posterior 42098X 27 559 178 1074 171 1571 166 
Midbrain 44986I 20 2601 860 5076 825 7624 849 
Pituitary 46848I 19 8012 2664 15590 2526 23474 2628 
Right orbit 29436W 156 8916 2920 17257 2780 25429 2724 
Left orbit 48908I 159 10531 3457 20203 3224 29830 3209 
Right lens of eye 41606Z 26 3993 1322 7885 1297 13447 1854 
Left Lens of eye 46757L 28 9091 3021 18008 2972 26645 2879 
Right cheek 409410 25 11283 3753 23137 3951 33587 3483 
Right parotid 27592Y 26 20946 6973 41295 6783 61635 6780 
Left parotid 37841X 23 22126 7368 43268 7047 64994 7242 
Right ramus 26177Z 24 16660 5545 33126 5488 48959 5278 
Left ramus 32758P 25 20776 6917 40878 6701 61096 6739 
Centre cervical spine 31835W 26 15467 5147 30682 5072 46662 5326 
Left back of neck 44131D 26 14888 4954 29766 4959 45804 5346 
Right mandible body upper 45032C 27 10287 3420 20686 3466 31160 3491 
Right mandible body lower 35299O 158 12480 4107 24701 4074 36750 4016 
Left mandible body upper 32817T 27 12404 4126 24570 4055 37065 4165 
Left mandible body lower 48629K 160 13443 4428 25831 4129 38810 4326 
Right submandibular gland 31657U 162 14824 4887 29631 4936 43213 4527 
Left submandibular gland 32871Z 146 16401 5418 31421 5007 47574 5384 
Centre sublingual gland 28791V 165 12486 4107 24382 3965 36662 4093 
Midline thyroid 46970B 20 2283 754 4495 737 6560 688 
Thyroid surface - left 294126 22 1266 415 2639 457 3912 424 
Esophagus 35015A 23 2117 698 4084 656 6197 704 
Background 321268 21 69 48 70 1 70 0 
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Appendix B:  Average OSLD Counts - Full Scan, HC/HR 
 
 
 
 
Baseline 14 mAs 
 
28 mAs 
 
Anatomic Location OSLD ID 
Avg 
Reading 
Avg 
Reading 
Net 
Count/3 
Average 
Reading 
Net 
Count/3 
Calvarium anterior 34151D 57 1305 416 3938 878 
Calvarium left 42477T 62 671 203 1878 402 
Calvarium posterior 42098X 55 195 47 485 96 
Midbrain 44986I 60 818 253 2395 525 
Pituitary 46848I 58 2401 781 7383 1661 
Right orbit 29436W 55 2687 877 8048 1787 
Left orbit 48908I 58 3096 1013 9387 2097 
Right lens of eye 41606Z 54 1237 394 3719 827 
Left Lens of eye 46757L 62 2816 918 8198 1794 
Right cheek 409410 72 3723 1217 11005 2428 
Right parotid 27592Y 65 6484 2140 19596 4370 
Left parotid 37841X 59 6994 2312 21369 4792 
Right ramus 26177Z 61 5221 1720 16129 3636 
Left ramus 32758P 63 6212 2050 19539 4442 
Centre cervical spine 31835W 59 4862 1601 15085 3408 
Left back of neck 44131D 57 4945 1629 15421 3492 
Right mandible body upper 45032C 63 3253 1063 9764 2170 
Right mandible body lower 35299O 65 3966 1300 12306 2780 
Left mandible body upper 32817T 63 3786 1241 11939 2717 
Left mandible body lower 48629K 61 4180 1373 12941 2920 
Right submandibular gland 31657U 60 4686 1542 14326 3213 
Left submandibular gland 32871Z 61 4930 1623 15378 3483 
Centre sublingual gland 28791V 56 3957 1300 12006 2683 
Midline thyroid 46970B 58 729 223 2288 520 
Thyroid surface - left 294126 50 512 154 1322 270 
Esophagus 35015A 52 685 211 2100 472 
Background 321268 52 56 4 58 2 
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Appendix C:  Average OSLD Counts - Maxillary Scan, HC/HR 
 
 
 
Baseline 14 mAs 
 
28 mAs 
 
42mAs 
 
Anatomic Location OSLD ID 
Avg 
Reading 
Avg  
Reading 
Net 
Count/3 
Avg 
Reading 
Net 
Count/3 
Avg 
Reading 
Net 
Count/3 
Calvarium anterior 34151D 66 1316 417 4265 983 8417 1384 
Calvarium left 42477T 62 691 210 2074 461 4045 657 
Calvarium posterior 42098X 61 175 38 462 96 873 137 
Midbrain 44986I 63 811 249 2421 537 4845 808 
Pituitary 46848I 63 2360 766 7409 1683 14856 2482 
Right orbit 29436W 59 2575 839 7924 1783 16181 2752 
Left orbit 48908I 60 3115 1018 9538 2141 19056 3173 
Right lens of eye 41606Z 65 1379 438 4545 1055 9416 1624 
Left Lens of eye 46757L 56 2741 895 8728 1996 17611 2961 
Right cheek 409410 60 3640 1193 11025 2462 22151 3709 
Right parotid 27592Y 67 6196 2043 19354 4386 38530 6392 
Left parotid 37841X 54 6874 2274 20662 4596 40791 6710 
Right ramus 26177Z 59 4965 1635 15084 3373 30711 5209 
Left ramus 32758P 69 6055 1995 18960 4302 37425 6155 
Centre cervical spine 31835W 62 4630 1523 14174 3181 28433 4753 
Left back of neck 44131D 63 1964 633 9152 2396 21077 3975 
Right mandible body upper 45032C 59 3109 1017 9533 2141 19199 3222 
Right mandible body lower 35299O 60 779 239 2168 463 4122 651 
Left mandible body upper 32817T 58 3531 1158 10727 2399 21451 3575 
Left mandible body lower 48629K 77 802 242 2541 580 4903 787 
Right submandibular gland 31657U 62 1386 441 3935 850 7764 1276 
Left submandibular gland 32871Z 63 1465 467 4562 1032 9181 1540 
Centre sublingual gland 28791V 61 1035 324 3094 686 6016 974 
Midline thyroid 46970B 54 326 91 937 204 1821 295 
Thyroid surface - left 294126 60 227 56 591 121 1176 195 
Esophagus 35015A 54 342 96 1053 237 2007 318 
Background 321268 55 57 1 70 4 57 -4 
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Appendix D:  Average OSLD Counts – Mandibular Scans, HC/HR 
 
  
Baseline 14 mAs 
 
28 mAs 
 
42mAs 
 
Anatomic Location OSLD ID 
Avg  
Reading 
Avg  
Reading 
Net  
Count/3 
Avg  
Reading 
Net  
Count/3 
Avg  
Reading 
Net  
Count/3 
Calvarium anterior 34151D 60 162 34 385 74 732 116 
Calvarium left 42477T 67 154 29 370 72 672 101 
Calvarium posterior 42098X 57 109 17 210 34 312 34 
Midbrain 44986I 64 205 47 559 118 1085 175 
Pituitary 46848I 53 371 106 1127 252 2176 350 
Right orbit 29436W 65 356 97 872 172 1756 295 
Left orbit 48908I 61 372 104 982 203 2022 347 
Right lens of eye 41606Z 60 171 37 438 89 866 142 
Left Lens of eye 46757L 68 194 42 517 108 973 152 
Right cheek 409410 57 3157 1034 7540 1461 14233 2231 
Right parotid 27592Y 69 5087 1673 15734 3549 31360 5209 
Left parotid 37841X 71 5479 1803 17106 3876 34553 5816 
Right ramus 26177Z 72 4417 1448 13677 3087 27206 4510 
Left ramus 32758P 70 5552 1828 16783 3743 33672 5630 
Centre cervical spine 31835W 74 3650 1192 11708 2686 23121 3805 
Left back of neck 44131D 65 4489 1474 14084 3199 27509 4475 
Right mandible body upper 45032C 62 2978 972 9192 2071 18736 3181 
Right mandible body lower 35299O 59 3885 1276 11812 2642 24356 4181 
Left mandible body upper 32817T 70 3512 1147 11156 2548 21446 3430 
Left mandible body lower 48629K 65 3744 1226 11981 2746 24373 4131 
Right submandibular gland 31657U 66 4279 1404 13393 3038 27137 4581 
Left submandibular gland 32871Z 62 4650 1529 14339 3230 29330 4997 
Centre sublingual gland 28791V 62 3738 1225 11549 2604 23114 3855 
Midline thyroid 46970B 57 638 194 2011 458 4021 670 
Thyroid surface - left 294126 58 380 108 1076 232 2117 347 
Esophagus 35015A 50 638 196 1760 374 3440 560 
Background 321268 48 51 1 62 4 57 -2 
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Appendix E:  Average OSLD Counts – Full Scans 
 
  Baseline    
#1  
NC/HR Baseline #2 
 
HC/NR 
 
NC/NR 
Anatomic Location OSLD ID Avg Reading 
Avg 
Reading 
Net 
Count/3 
Avg 
Reading 
Avg 
Reading 
Net 
Count/3 
Avg 
Reading 
Net 
Count/3 
Calvarium anterior 34151D 3938 7888 1317 60 4793 1577 9179 1462 
Calvarium left 42477T 1878 3873 665 61 2307 748 4459 717 
Calvarium posterior 42098X 485 983 166 70 507 145 1036 177 
Midbrain 44986I 2395 4821 809 63 2642 859 5151 837 
Pituitary 46848I 7383 15020 2546 53 8042 2663 15743 2567 
Right orbit 29436W 8048 16594 2849 61 8602 2847 17043 2814 
Left orbit 48908I 9387 19223 3279 55 10033 3326 19828 3265 
Right lens of eye 41606Z 3719 8339 1540 70 5677 1869 11785 2036 
Left Lens of eye 46757L 8198 17432 3078 60 9376 3105 18130 2918 
Right cheek 409410 11005 21724 3573 60 11908 3949 23086 3726 
Right parotid 27592Y 19596 39577 6660 63 20596 6844 41125 6843 
Left parotid 37841X 21369 45877 8169 61 21888 7276 43055 7056 
Right ramus 26177Z 16129 31607 5159 61 16939 5626 33418 5493 
Left ramus 32758P 19539 39728 6730 66 20044 6659 39572 6509 
Centre cervical spine 31835W 15085 30368 5094 63 15463 5133 30561 5033 
Left back of neck 44131D 15421 31345 5308 61 15083 5007 30760 5226 
Right mand. body upper 45032C 9764 19446 3227 74 10849 3592 21301 3484 
Right mand. body lower 35299O 12306 24222 3972 73 12568 4165 25156 4196 
Left mand. body upper 32817T 11939 23750 3937 64 12267 4068 24397 4043 
Left mand. body lower 48629K 12941 25711 4257 58 13154 4365 26007 4284 
Right submand. gland 31657U 14326 28467 4714 58 14714 4886 29029 4772 
Left submand. gland 32871Z 15378 31108 5243 62 15673 5204 31181 5169 
Centre sublingual gland 28791V 12006 24046 4013 58 12370 4104 24684 4105 
Midline thyroid 46970B 2288 4602 771 56 2173 706 4185 671 
Thyroid surface - left 294126 1322 2677 452 63 1227 388 2542 438 
Esophagus 35015A 2100 4132 677 64 2026 654 3957 644 
Background 321268 58 54 -4 61 60 0 59 0 
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